Table 3 Comparison of incidence of postoperative adverse events in two cohorts.
From: The role of ROSE-enhanced ERCP-guided biopsy in diagnosing biliary stricture
Cohort | Patient (n) | Complication [n, (%)] | Total cases (n) | Incidence rate (%) | ||
|---|---|---|---|---|---|---|
Biliary tract hemorrhage | Cholangitis | Hepatic duct perforation | ||||
ROSE | 100 | 1(1.00) | 0 | 0 | 1 | 1.00 |
NON-ROSE | 100 | 3(3.00) | 0 | 1(1.00) | 4 | 4.00 |
χ2 value | – | 0.2551 | – | 0 | – | 0.82 |
P value | – | > 0.05 | – | > 0.05 | – | > 0.05 |
